Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: rubitecan
Sponsor: Astex Pharmaceuticals, Inc.